Detection of unknown occult primary tumors using positron emission tomography

作者: Annemieke C. Kole , Omgo E. Nieweg , Jan Pruim , Harald J. Hoekstra , Heimen Schraffordt Koops

DOI: 10.1002/(SICI)1097-0142(19980315)82:6<1160::AID-CNCR22>3.0.CO;2-3

关键词: Primary tumorCarcinomaBreast carcinomaMelanomaMedicinePlasmacytomaNuclear medicineCancerFluorodeoxyglucosePositron emission tomography

摘要: BACKGROUND. The potential of positron emission tomography (PET) with F-18-fluoro-2-deoxy-D-glucose (FDG) to detect primary tumors after unsuccessful conventional diagnostic workup was assessed in patients metastatic disease from an unknown tumor. METHODS. Twenty-nine various histologic types metastases site were studied workup. received 370 megabecquerels (MBq) (10 millicuries) FDG intravenously and whole body scans made 30 minutes injection onward. RESULTS, All but one known tumor sites visualized. Additional discovered five patients. With FDG-PET the identified 7 (24%): 2 carcinoma nasopharynx, I patient plasmacytoma base tongue, 1 lung, colon, breast carcinoma. did not identify a remaining 22 (76%). Despite negative PET study, lesion later phase 3 these (14%). Survival altered by discovery CONCLUSIONS. A previously turner able be 29 However, clinical relevance information this setting is limited. (C) 1998 American Cancer Society.

参考文章(23)
Heffelfinger-Juttner J, Nystrom Js, Weiner Jm, Irwin Le, Bateman, Wolf Rm, Metastatic and histologic presentations in unknown primary cancer. Seminars in Oncology. ,vol. 4, pp. 53- 58 ,(1977)
Armando E. Giuliano, Alistair J. Cochran, Donald L. Morton, Melanoma from unknown primary site and amelanotic melanoma Seminars in Oncology. ,vol. 9, pp. 442- 447 ,(1982) , 10.5555/URI:PII:0093775482900690
OMGO E. NIEWEG, WAI-HOI WONG, SONJA E. SINGLETARY, GABRIEL N. HORTOBAGYI, E. EDMUND KIM, Positron emission tomography of glucose metabolism in breast cancer. Potential for tumor detection, staging, and evaluation of chemotherapy. Annals of the New York Academy of Sciences. ,vol. 698, pp. 423- 428 ,(1993) , 10.1111/J.1749-6632.1993.TB17236.X
M.E. Phelps, E.J. Hoffman, M. Dahlbom, C.K. Hoh, G. Rosenqvist, R.A. Hawkins, C. Schiepers, Whole-body positron emission tomography: Part I. Methods and performance characteristics. The Journal of Nuclear Medicine. ,vol. 33, pp. 1191- 1199 ,(1992)
J Pruim, RJ vanGinkel, W Vaalburg, H. Schraffordt Koops, Amj Paans, OE Nieweg, WM Molenaar, HJ Hoekstra, Fluorine-18-Fluorodeoxyglucose PET Imaging of Soft-Tissue Sarcoma The Journal of Nuclear Medicine. ,vol. 37, pp. 257- 261 ,(1996)
J L Abbruzzese, M C Abbruzzese, R Lenzi, K R Hess, M N Raber, Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. Journal of Clinical Oncology. ,vol. 13, pp. 2094- 2103 ,(1995) , 10.1200/JCO.1995.13.8.2094
Ulla Ruotsalainen, Sirkku Leskinen-Kallio, Kjell Någren, Heikki Joensuu, Mika Teräs, Uptake of Carbon-11-Methionine and Fluorodeoxyglucose in Non-Hodgkin's Lymphoma: A PET Study The Journal of Nuclear Medicine. ,vol. 32, pp. 1211- 1218 ,(1991)
J F Stewart, M H Tattersall, R L Woods, R M Fox, Unknown primary adenocarcinoma: incidence of overinvestigation and natural history. BMJ. ,vol. 1, pp. 1530- 1533 ,(1979) , 10.1136/BMJ.1.6177.1530
T. Bury, A. Dowlati, P. Paulus, R. Hustinx, M. Radermecker, P. Rigo, Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 23, pp. 204- 206 ,(1996) , 10.1007/BF01731846
Carl K. Hoh, Randall A. Hawkins, Magnus Dahlbom, John A. Glaspy, Leanne L. Seeger, Yong Choi, Christiaan W. Schiepers, Sung-cheng Huang, Nagichettiar Satyamurthy, Jorge R. Barrio, Michael E. Phelps, Whole body skeletal imaging with [18F]fluoride ion and PET. Journal of Computer Assisted Tomography. ,vol. 17, pp. 34- 41 ,(1993) , 10.1097/00004728-199301000-00005